AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus by 萩原 大祐 et al.
AtrR Is an Essential Determinant of Azole
Resistance in Aspergillus fumigatus
著者（英） Sanjoy Paul, Mark Stamnes, Grace Heredge
Thomas, Hong Liu, Daisuke HAGIWARA, Katsuya
Gomi, Scott G. Filler, W. Scott Moye-Rowley
journal or
publication title
mBio
volume 10
number 2
page range e02563-18
year 2019-03
権利 (C) 2019 Paul et al. This is an openaccess
article distributed under the terms of the
Creative Commons Attribution 4.0 International
license.
URL http://hdl.handle.net/2241/00159460
doi: 10.1128/mBio.02563-18
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
AtrR Is an Essential Determinant of Azole Resistance in
Aspergillus fumigatus
Sanjoy Paul,a Mark Stamnes,a Grace Heredge Thomas,a Hong Liu,b Daisuke Hagiwara,d Katsuya Gomi,e Scott G. Filler,b,c
W. Scott Moye-Rowleya
aDepartment of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
bDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA
cDavid Geffen School of Medicine at UCLA, Los Angeles, California, USA
dFaculty of Life and Environmental Sciences, University of Tsukuba, Ibaraki, Japan
eGraduate School of Agricultural Science, Tohoku University, Sendai, Japan
ABSTRACT Aspergillosis associated with azole-resistant Aspergillus fumigatus has a
mortality rate that can approach 90% in certain patient populations. The best-
understood avenue for azole resistance involves changes in the cyp51A gene that
encodes the target of azole drugs, lanosterol -14 demethylase. The most common
azole resistance allele currently described is a linked change corresponding to a
change in the coding sequence of cyp51A and a duplication of a 34-bp region in the
promoter leading to a tandem repeat (TR). Our previous studies identiﬁed a posi-
tively acting transcription factor called AtrR that binds to the promoter of cyp51A as
well as that of an important membrane transporter protein gene called abcG1. In
this work, we characterize two different mutant alleles of atrR, either an overproduc-
ing or an epitope-tagged form, causing constitutive activation of this factor. Using
an epitope-tagged allele of atrR for chromatin immunoprecipitation coupled with
high-throughput sequencing (ChIP-seq), the genomic binding sites for AtrR were de-
termined. Close to 900 genes were found to have an AtrR response element (ATRE)
in their promoter regions. Transcriptome evaluation by RNA sequencing (RNA-seq)
indicated that both alleles led to elevated transcription of a subset of target genes.
An electrophoretic mobility shift assay and DNase I protection mapping localized the
ATREs in both the abcG1 and cyp51A promoters. The ATRE in cyp51A was located
within the 34-bp repeat element. Virulence in a murine model was compromised
when AtrR was either deleted or overproduced, indicating that the proper dosage of
this factor is key for pathogenesis.
IMPORTANCE Aspergillus fumigatus is the major ﬁlamentous fungal pathogen in hu-
mans. Infections associated with A. fumigatus are often treated with azole drugs, but
resistance to these antifungal agents is increasing. Mortality from aspergillosis asso-
ciated with azole-resistant fungi is extremely high. Previous work has identiﬁed tran-
scriptional control of the azole drug target-encoding gene cyp51A as an important
contributor to resistance in A. fumigatus. Here, we demonstrate that the transcrip-
tion factor AtrR binds to a region in the cyp51A promoter that is associated with al-
leles of this gene conferring clinically important azole resistance. Using high-
throughput genomic technologies, we also uncover a large suite of target genes
controlled by AtrR. These data indicate that AtrR coordinately regulates many differ-
ent processes involved in drug resistance, metabolism, and virulence. Our new un-
derstanding of AtrR function provides important new insight into the pathogenesis
of A. fumigatus.
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Infections associated with azole-resistant forms of Aspergillus fumigatus have a mor-tality rate that can approach 90% in particular patient populations (discussed in
reference 1). This places a high priority on understanding the molecular basis of
development of this problematic phenotype. Extensive studies from several laborato-
ries have provided support for the prevalence of a compound mutation in the cyp51A
gene that encodes the target enzyme of azole drugs, lanosterol -14 demethylase
(recently reviewed in reference 2). This interesting compound mutation consists of a
change within the cyp51A open reading frame that replaces a leucine at position 98
with a histidine residue (L98H) and contains a duplication of a 34-bp region in the
promoter (tandem repeat of 34 bp [TR34]) (3). These linked changes cause elevated
cyp51A mRNA levels and produce an altered enzyme that is believed to have a defect
in azole drug binding (4, 5). Both of these alterations must be present for the synergistic
increase in azole resistance to occur (6). Other alterations in the cyp51A promoter that
duplicate similar regions have been described, with these changes sharing the common
feature of elevating transcription of cyp51A (7, 8).
The requirement for increased transcription of cyp51A makes analyzing the tran-
scriptional control mechanisms of this gene an important step in developing strategies
to interfere with acquisition of azole resistance. A recent detailed analysis has provided
new insights into the function of both the wild-type cyp51A promoter and the TR34
derivative (9). A binding site for the important positive transcriptional regulator of
ergosterol biosynthetic enzyme-encoding genes called SrbA was found to bind to the
34-bp region, and this binding element was designated the SrbA response element
(SRE) (9). Two SREs were localized to the 34-bp region and shown to be duplicated in
the TR34 mutation. Additional regulatory sites have been documented for the nega-
tively acting factors CCAAT-binding complex (CBC) and HapX (10). The CBC is a complex
of three proteins (HapB, HapC, and HapE) (reviewed in reference 11) that act along with
HapX to repress the transcription of cyp51A and a number of other loci encoding
enzymes required for ergosterol production and iron homeostasis (12). Mutation of
either the hapE or hapX gene led to elevated azole resistance and increased cyp51A
transcription (9).
A new participant in the transcriptional control of cyp51A gene expression was
recently discovered to be a Zn2Cys6 cluster-containing transcription factor that was
able to elevate azole resistance when overproduced in Aspergillus oryzae (13). This
factor, designated ABC transporter regulator, or AtrR, was found to be present in A.
fumigatus and to be required for normal azole tolerance. AtrR was linked to regulation
of both cyp51A and the ATP-binding cassette (ABC) transporter-encoding gene abcG1
(also known as [aka] cdr1B) by two pieces of evidence. First, strains lacking atrR failed
to drive normal transcription of either cyp51A or abcG1. Second, chromatin immuno-
precipitation (ChIP) experiments demonstrated that AtrR bound to both the cyp51A and
abcG1 promoter regions. However, the sequence of the AtrR response element (ATRE),
its relationship to the SRE, and the genomic target sites of this factor remained among
the gaps in our knowledge.
Here, we report the generation of two hypermorphic or hyperactive alleles of atrR,
as well as identiﬁcation of the suite of AtrR-responsive genes in vivo using chromatin
immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-seq). The
sequence of the ATRE was identiﬁed from these analyses and conﬁrmed by a combi-
nation of DNase I footprinting, electrophoretic mobility shift assays (EMSA), and mu-
tagenesis. AtrR and SrbA both bind to the critical 34-bp region of cyp51A and are likely
to cooperate to drive the transcription of this key azole resistance determinant, while
only AtrR appears to control abcG1 transcription.
RESULTS
Generation of two hypermorphic alleles of atrR. We previously generated an
epitope-tagged form of atrR corresponding to the wild-type gene containing a
C-terminal insertion of a 3 hemagglutinin (3 HA) tag (13). More recently, we
replaced the endogenous atrR promoter with the cognate region from the highly
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transcribed hspA gene (14). Based on RNA-seq analyses (15), we estimate that this hspA
allele has the potential to overproduce atrR mRNA by at least 10-fold. To compare the
functions of these different forms of atrR, we placed appropriate transformants on
minimal medium lacking or containing 0.1 g/ml voriconazole. We also included
isogenic wild-type atrRΔ null cells for comparison along with an hspA-atrR-3 HA allele
used earlier. Plates were incubated at 37°C to evaluate the relative resistance conferred
by these different atrR alleles (Fig. 1A).
The presence of the hspA promoter upstream of atrR, either tagged with 3 HA or
untagged, strongly elevated voriconazole resistance. Interestingly, even insertion of the
3 HA epitope tag alone was sufﬁcient to elevate azole resistance. These data suggest
that fusion of foreign sequences to the C terminus or overproduction of AtrR (see
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FIG 1 Azole resistance phenotypes of atrR alleles. (A) Isogenic wild-type (wt) AfS35 strains were
produced that contained the indicated forms of the atrR gene. The wild-type atrR gene was replaced with
the hygromycin resistance gene (atrRΔ) or a 3 HA epitope tag inserted at its C terminus (atrR-3 HA).
The strong hspA promoter region was used to drive either the wild-type atrR coding sequence (hspA-atrR)
or the epitope-tagged allele (hspA-atrR-3 HA). Equivalent numbers of spores from representative
transformants were prepared and spotted on solid minimal medium (MM) or the same medium
containing voriconazole (MM  Vori). Plates were incubated at 37°C and then photographed. Corre-
sponding MICs for voriconazole (MIC Vori) were determined for each strain and are listed below in
micrograms per milliliter. (B) Spore suspensions were prepared from wild-type and abcG1Δ cells
containing an hspA-atrR fusion gene where indicated or retaining the wild-type atrR locus. Voriconazole
resistance was assayed as described above.
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below) both represent means of overcoming the normal control of transactivation by
this transcription factor.
Work from several labs has implicated an ATP-binding cassette (ABC) transporter-
encoding gene, here called abcG1, as being an important determinant in azole resis-
tance (16, 17), as well as being a target gene for AtrR regulation (13). To examine the
epistatic relationship between AtrR and abcG1, we constructed isogenic hspA-atrR
strains that contained or lacked a copy of abcG1. We compared these strains for
resistance to voriconazole as described above along with wild-type and abcG1Δ control
strains (Fig. 1B).
A loss of abcG1 strongly depressed voriconazole resistance in a strain overproducing
AtrR. However, even in the absence of abcG1, overproduction of AtrR was still able to
elevate azole resistance. This is consistent with abcG1 being an important but not
exclusive target gene of AtrR impacting voriconazole resistance.
Expression of abcG1 responds to hypermorphic alleles of atrR. To conﬁrm that
increased AtrR levels led to increased expression of AbcG1, we directly assayed the
expression of these two proteins using polyclonal antibodies directed against recom-
binant forms of each. Isogenic wild-type and atrRΔ strains were grown in minimal
medium, along with transformants containing the epitope-tagged atrR allele (atrR-3
HA) or strains with the hspA promoter in place of the wild-type atrR promoter driving
the native (hspA-atrR) or epitope-tagged (hspA-atrR-3 HA) allele. Whole-cell protein
extracts were prepared from these strains and analyzed by Western blotting using
anti-AtrR or anti-AbcG1 antiserum.
AtrR was seen as a 100-kDa protein in extracts from wild-type cells that was
eliminated in atrRΔ cells (Fig. 2A). The presence of the hspA promoter in place of the
wild-type atrR promoter led to the overproduction of AtrR. The epitope-tagged form of
AtrR was expressed at levels similar to those in the wild type, irrespective of being
under wild-type or hspA promoter control. Our use of the anti-AtrR antibody allowed
facile comparison of levels of tagged and untagged transcription factors. The size of this
polypeptide was increased by the presence of the 3 HA tag, as expected; however,
the steady-state level of this form of AtrR was not increased when under hspA promoter
control, unlike the effect seen for the wild-type factor. These data conﬁrm that the
wild-type protein was overproduced when driven from the hspA promoter, as sug-
gested above.
The expression of AbcG1 was strongly responsive to the presence of atrR (Fig. 2B),
consistent with earlier data (13). Both overproduction of the native AtrR protein and the
presence of the epitope-tagged atrR allele increased the expression of AbcG1.
We next measured expression levels of the mRNA for atrR and abcG1 to determine
if these changes at the protein level correlated with the expected alterations in
gene transcription. Wild-type and atrRΔ, atrR-3 HA, and hspA-atrR mutant strains
were grown to mid-log phase, total RNA was prepared, and quantitative reverse
transcription-PCR (qRT-PCR) was used to evaluate mRNA levels for atrR and abcG1.
The transcription of atrR was increased in the presence of the hspA-atrR allele but
was not altered by the insertion of the epitope tag at the C terminus of the native gene
(Fig. 2C). In contrast, abcG1 transcription was similarly increased by the presence of
either hypermorphic allele of atrR (Fig. 2D). We suggest from these data that the causes
of the increased abcG1 expression induced by the presence of the epitope-tagged or
the hspA-driven allele of atrR are different and discuss this more fully below.
Genomic target genes of AtrR. We have previously shown that AtrR binds directly
to the promoters of abcG1 and cyp51A in vivo by single-gene chromatin immunopre-
cipitation (ChIP) analyses (13). To determine the range of target genes of AtrR in the
entire A. fumigatus genome, we carried out ChIP coupled with high-throughput se-
quencing (ChIP-seq) using the atrR-3 HA and hspA-atrR-3 HA strains. Wild-type
(negative control), atrR-3 HA, and hspA-atrR-3 HA strains were grown to mid-log
phase and cross-linked chromatin prepared, as described previously (18). Isolated
chromatin prepared for next-generation sequencing using standard methods (19) and
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the sequencing reads were mapped to the A. fumigatus genome sequence. Signiﬁcantly
increased read depth peaks were called by comparison to untagged wild-type controls
and assessed for proximity to annotated protein-coding genes. We found nearly 900
peaks for AtrR binding in the promoter regions of protein-coding genes. Plots of
representative ChIP densities are shown in Fig. 3A.
As expected from our single-gene ChIP data (13), we found signiﬁcant AtrR binding
to regions upstream of both abcG1 and cyp51A. Interestingly, we also found evidence
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FIG 2 Regulation of expression by AtrR. (A) A rabbit polyclonal directed against the AtrR DNA-binding domain was generated against a recombinant form
of this protein domain. Whole-cell protein extracts were prepared from isogenic wild-type (atrR), atrRΔ mutant, atrR-3 HA mutant, hspA-atrR mutant, or
hspA-atrR-3 HA mutant strains. Equal amounts of protein were resolved on SDS-PAGE gel and then transferred to nitrocellulose membranes. These
membranes were stained with Ponceau S to ensure equal loading and then analyzed by Western blotting using an anti-tubulin antibody (Ab) and the
anti-AtrR antibody. Molecular mass standards are indicated on the left side of the panel. (B) Whole-cell protein extracts were prepared from the indicated
strains and analyzed by Western blotting using anti-AbcG1 antiserum (16). (C) RNA levels for atrR were assessed using qRT-PCR. Total RNA was prepared from
the strains listed at the bottom and atrRmRNA measured using speciﬁc primers. Actin mRNA was used as an internal standard, and RNA levels are normalized
those produced in wild-type cells. P values were determined by an unpaired 2 tailed t-test and are reported above each comparison as NS, not signiﬁcant;
*, P  0.05; **, P  0.005; ***, P  0.001. (D) Levels of abcG1 mRNA were determined via qRT-PCR.
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for AtrR binding to the promoter regions of both the srbA and atrR genes themselves.
The srbA gene encodes the previously characterized sterol response transcription factor
SrbA (20), while AtrR binding to its own promoter suggests the possibility that atrR is
autoregulated.
As the speciﬁc element recognized by AtrR is not well understood, we compared the
sequences of all the detected ChIP-seq peaks using the algorithm MEME-ChIP (21). This
algorithm compares sequences surrounding each of the annotated peak summits to
search for a shared common element. This analysis predicted the presence of two most
common shared elements shown in Fig. 3B. We believe that motif 1 represents the
half-site of an AtrR response element (ATRE), while motif 2 corresponds to the binding
site for the SrbA transcription factor (SrbA response element [SRE]). Motif 1 was present
in approximately 600 of the ChIP-seq peaks, while motif 2 was found in 400 peaks.
Interestingly, these were present at the same promoter in roughly 100 genes. These
sequences are analyzed in more detail below.
We next validated that DNA regions containing these different ATREs could be
bound by a recombinant form of AtrR corresponding to the N-terminal DNA-binding
domain of the factor. In all cases, each probe was produced by PCR ampliﬁcation from
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FIG 3 DNA site selection by AtrR. (A) Chromatin immunoprecipitation–high-throughput sequencing
(ChIP-seq) was used to proﬁle genomic sites of AtrR-3 HA binding. ChIP-seq proﬁles of several selected
genes are shown as diagrams of the read density in their respective promoter regions (top line of each
pair) along with a map of the genes around these elements. The direction of gene transcription is
indicated by the arrows within the boxed exons. The scale of these diagrams is indicated at the bottom
by the line labeled 500 bp. (B) MEME-ChIP analysis of binding sites enriched in ChIP-seq peaks is shown
as a MEME logo. Higher levels of conservation are indicated by the larger letters. Motif 1 is likely to be
an AtrR response element (ATRE), while motif 2 is an SrbA response element (SRE). (C) Electrophoretic
mobility shift assays (EMSA) of regions containing putative ATREs located upstream of the indicated
genes. Probes from each gene were prepared by PCR and end-labeled with [-32P]-ATP and T4
polynucleotide kinase. Puriﬁed probe fragments were mixed with recombinant AtrR in the presence or
absence of a molar excess of the unlabeled probe. After binding, these reaction mixtures were separated
by nondenaturing 5% acrylamide PAGE gels, the gels were dried, and labeled fragments were detected
by use of a Typhoon imager. AtrR-DNA complexes are indicated by the arrows.
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A. fumigatus genomic DNA, radiolabeled, and incubated with the bacterially produced
AtrR alone or in the presence of a 40-fold molar excess of the unlabeled probe. We also
used a region from the promoter of the actin-encoding actA gene as a control for
nonspeciﬁc binding. After formation of protein-DNA complexes, these reaction mix-
tures were separated on a nondenaturing 5% polyacrylamide gel and detected by
autoradiography (Fig. 3C).
AtrR was able to bind to all these target genes containing ATREs, while no binding
was seen to the actA promoter. These data support the coincidence of ChIP-seq binding
peaks and bona ﬁde ATREs in the A. fumigatus genome.
Comparison of the functions of the proteins produced from these potential regu-
latory targets of AtrR indicated that several gene ontology (GO) terms were enriched.
The most enriched GO terms included sequence-speciﬁc DNA binding, plasma mem-
brane, and several metabolic processes (see Fig. S1 in the supplemental material). The
list of sequence-speciﬁc DNA-binding protein-encoding genes consisted of 42 genes
and included loci previously shown to inﬂuence azole resistance, such as srbA (22), srbB
(18), and yap1 (23). This large number (42) (see Table S1) of transcriptional regulators
suggests the possibility that their regulation by AtrR might lead to an ampliﬁcation of
the effect of AtrR through the action of these downstream regulators, a suggestion we
support below.
Previous ChIP-seq experiments have identiﬁed the potential targets for SrbA gene
regulation (18). Since cyp51A has already been demonstrated to be a target gene for
both SrbA and AtrR regulation (13), we wondered if other genes might be regulated by
both AtrR and SrbA (Fig. S2). Comparing the ChIP-seq data for these factors, we found
that 51 genes were present in lists of ChIP-seq-positive targets for both AtrR and SrbA
(Fig. 4A). These include ergosterol biosynthetic genes like cyp51A, cyp51B, erg3A, erg5,
and erg25 (recently reviewed in reference 2), transcription factors such as srbA itself and
srbB, iron uptake (ftrA) (24), and a heme biosynthesis gene (hem13) (20). As the total
number of SrbA-regulated genes was estimated to be 126, almost 50% of these are also
predicted to contain ATREs, indicating extensive overlap between these two transcrip-
tion factors. This extensive overlap helps explain why the SRE was the second most
common enriched motif found in our MEME-ChIP analysis.
Transcriptomic proﬁling of hyperactive alleles of atrR. Since a large number of
genes were predicted to have binding sites for AtrR in their promoters, we wanted to
determine the range of genes that responded to the two different hyperactive alleles,
the hspA overproduction derivative and the 3 HA-tagged form. Isogenic wild-type
and atrRΔ, hspA-atrR, and atrR-3 HA mutant strains were grown in minimal medium.
Total RNA was prepared and analyzed by RNA-seq, as described previously (15). The top
50 upregulated genes clustered by regulatory pattern are shown in Fig. 5A.
A total of 633 genes were upregulated by at least 2-fold in the presence of the
hspA-atrR, while the epitope-tagged allele exhibited 293 genes that were upregulated
by this same degree. Importantly, only around 20% of these upregulated genes were
also found to be positive for the presence of an ATRE as assessed by ChIP-seq. The most
highly induced gene in the presence of either hyperactive allele was the abcG1 gene.
GO terms for the top 100 genes in the cluster analysis showed enrichment for genes
involved in oleate metabolism and gliotoxin biosynthesis, but these two groups only
involved 5 genes total (data not shown). We also compared the effects seen when atrR
was deleted with results from our earlier study (13). Of the 200 genes that showed the
greatest reduction in expression upon loss of atrR, only approximately 10% were seen
to overlap between the current RNA-seq measurement and in the previous assay (13).
This is likely due to cells being grown as a bioﬁlm in these experiments, while in the
previous assays, cells were grown planktonically. Large differences in transcription have
previously been reported in a comparison of genes grown under these different
conditions (15).
The overlap between upregulated genes in either hyperactive allele was compared
along with the total number of ChIP-positive genes (Fig. 5B). Only 38 (2.5% of the total)
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genes were upregulated in the presence of one or both hyperactive alleles and
contained ATREs. Additionally, the effect of overproduction of wild-type AtrR (in the
hspA-atrR fusion) had a stronger phenotypic response than did the presence of the
atrR-3 HA allele, as evidenced by the larger number of genes that were induced in
response to the hspA-atrR allele. These data support the view that much of the
AtrR-responsive regulon occurs via indirect effects through the engagement of other
transcription factor networks (like SrbA) and others identiﬁed in the ChIP-seq analysis
described above. This also supports the suggestion made above that the effects of AtrR
are ampliﬁed via induction of the large number of transcription factor-encoding genes
containing ATREs.
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FIG 4 Shared target genes of AtrR and SrbA. (A) A diagram representing the genes that contain both an ATRE as predicted from the
ChIP-seq data reported here and a SRE as found in reference 18. (B) FungiFun2 (42) was used to identify GO terms enriched in these genes.
SREBP, SRE binding protein.
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FIG 5 RNA-seq analysis of atrR alleles. (A) A heat map of the RNA-seq data obtained from use of RNA prepared from isogenic wild-type,
atrRΔ (null) mutant, hspA-atrR (hspA) mutant, and atrR-3 HA (HA) strains is shown. Colors represent the log2 values of the ratio of RNA
levels detected in the indicated strains at the top relative to those present in the wild-type cells. The presence of an ATRE in the promoter
region of each gene is indicated by the  symbol. (B) Venn diagram showing the union of all ChIP-seq-positive genes with the genes
corresponding to transcripts overproduced by a log2 of 1 or greater in strains containing either hyperactive allele of atrR. The percent
value represents the portion each category makes up of the total number of genes analyzed here. pol, polymerase.
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A hyperactive allele of atrR cannot suppress phenotypes of a srbA strain.
While the data described above provided several links between AtrR and SrbA func-
tions, we wanted to examine the interaction of these two important genes that impact
related in vivo processes. We employed genetic epistasis to determine if the hyper-
morphic hspA-atrR allele was capable of suppressing the well-described azole sensitivity
of a srbAΔ null strain. Isogenic wild-type and atrRΔ, srbAΔ, hspA-atrR, and hspA-atrR
srbAΔ mutant strains were grown and tested using a disk diffusion assay. Plates were
incubated at 37°C and photographed (Fig. 6).
While overproduction of AtrR strongly elevated voriconazole resistance in an oth-
erwise wild-type genetic background, the loss of srbA completely blocked this effect.
The epistasis of srbA to the hspA-atrR allele was also seen when testing for ﬂuconazole
resistance or hypoxic growth (data not shown). Both of these genes are required for
normal azole resistance and driving high-level expression of AtrR cannot suppress the
need for SrbA under these conditions.
Interaction of AtrR with the cyp51A 34-bp element. While the ChIP-seq data
implicated a region in the 34-bp region of the cyp51A promoter as the binding site for
AtrR, we wanted to precisely locate this element and support our identiﬁcation of the
ATRE. Additionally, we wanted to compare where SrbA bound to the 34-bp repeat with
the ATRE and previous data using a plasmon resonance approach (9). We used our
recombinant forms of SrbA and AtrR in a DNase I protection assay on the cyp51A
promoter region. Purine- and pyrimidine-speciﬁc reactions were also carried out on this
same probe to provide a means of mapping protected areas back to the DNA sequence.
Limited DNase I digestions were performed on the free probe or this same probe bound
to SrbA and/or AtrR. All samples were then electrophoresed through denaturing
acrylamide gels and DNA fragments detected by autoradiography (Fig. 7A).
AtrR protected a roughly 25-bp region containing the ATRE from DNase I cleavage.
This ATRE was located immediately upstream of the CBC-binding site mapped earlier
(9). SrbA bound to an SRE that was previously mapped and designated SRE1. A
downstream SRE that overlapped with the ATRE, called SRE2, was not protected from
DNase I cleavage in this assay. This likely reﬂects the ﬁnding that the Kd (dissociation
wt
atrR
srbA
hspA-atrR
FLCVori
FIG 6 Hypermorphic atrR allele cannot suppress the phenotype of a srbAΔ strain. The indicated strains
were analyzed using a zone of inhibition test employing the azole drugs listed (Vori, voriconazole; FLC,
ﬂuconazole).
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constant) for SrbA binding to SRE2 is 10-fold higher than for SRE1 (9). Together, these
data suggest that only SRE1 may play a relevant role in vivo.
To probe the speciﬁc sequence elements in the ATRE that are important for AtrR
recognition, we used an electrophoretic mobility shift assay (EMSA) with the 34-bp
region of cyp51A as the probe. This was chemically synthesized with a biotin moiety
attached to the 5= end of each oligonucleotide used to generate the probe. We also
produced nonbiotinylated competitor oligonucleotides corresponding to a mutant
with a 6-bp substitution in the region between the two CCG repeats (EcoRI), a 4-bp
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FIG 7 AtrR binding to cyp51A. (A) A 5=-end-labeled probe corresponding to the cyp51A promoter region
was prepared and used in Maxam-Gilbert chemical sequencing reactions (AG, purine residues; CT,
pyrimidine residues) to generate a size standard to allow localization of the binding sites for AtrR and
SrbA. This same probe was then used in a standard DNase I protection assay with the addition of
recombinant forms of AtrR or SrbA where indicated. The drawing on the left represents the sequence
elements of interest. The gray bar denotes the bounds of the 34-bp region that is duplicated in the TR34
promoter mutation. The double-headed arrow labeled CBC indicates the previously shown binding site
for the CAAT-binding complex (9), and the sequence in blue represents a previously mapped SrbA
response element (SRE) from this same earlier study. The AtrR response element (ATRE) is indicated with
the two CGG repeats in green text. (B) Electrophoretic mobility shift assay (EMSA) analysis of sequence
requirements for AtrR binding. A biotin-labeled form of the 34-bp element from cyp51A was used as a
probe for all these EMSA reactions. Recombinant forms of SrbA or AtrR were added to this probe in the
absence or presence of the indicated nonbiotinylated competitor DNAs listed at the bottom. Protein-
DNA complexes formed by SrbA. The locations of the SRE and ATRE are shown as in panel A, with mutant
residues indicated by red text. All competitors were present at 10-fold molar excess.
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replacement mutant in the upstream CCG repeat (SphI), or with a mutant lacking both
copies of the CCG repeat (DM). These unlabeled oligonucleotides were used as com-
petitors to determine if they retained the ability to block AtrR binding to the biotin-
ylated 34-bp probe. Recombinant proteins were added to the biotinylated probe in the
absence or the presence of the indicated competitor DNAs. After binding, free probe
and protein-probe complexes were resolved on nondenaturing acrylamide gels, trans-
ferred to nylon membranes, and visualized by blotting with an IRDye-labeled strepta-
vidin (Fig. 7B).
AtrR formed a complex with the 34-bp probe that could be competed away using
either a 42-bp version of this promoter fragment or the same 42-bp competitor
containing the 6-bp mutation between the two CCG repeats. Importantly, mutant
competitors lacking either one (SphI) or both CCG repeats (DM) could not compete.
These data conﬁrm the importance of these CCG repeats in normal DNA binding of the
ATRE by AtrR.
A region containing tandem ATREs is important for normal abcG1 expression.
We previously described the use of a ﬁreﬂy luciferase reporter system to compare
expression of the abcG1 gene and a homologue called abcG4 (Afu2g15130). The region
1,000 bp upstream of the ATG codon for both these genes was used to drive luciferase
expression, and the resulting fusion constructs produced similar low-level luciferase
expression (14). This was surprising since qRT-PCR analyses of these same gene
indicated that abcG1 mRNA was 4-fold higher than that of abcG4.
Our ﬁnding of AtrR binding to a region more than 1,000 bp upstream of the ATG by
ChIP-seq suggested a possible explanation for this observation, as we may have
inadvertently truncated the abcG1 promoter in our original construct. To test this
hypothesis, we produced a new fusion construct that extended to 1,300 bp upstream
of the ATG and contained the predicted ATREs for abcG1. We introduced this longer
construct, along with our original fusion and a no-promoter control into wild-type,
atrRΔ mutant, and hspA-atrR mutant cells. Representative transformants were grown
overnight and then levels of abcG1 promoter-driven luciferase assayed (Fig. 8A).
The 1.3-kb promoter region was expressed more highly than the 1-kb construct in
all genetic backgrounds. This is most dramatically seen in the presence of the hyper-
morphic allele of atrR in which luciferase levels of the 1.3-kb reporter construct were
nearly 4-fold elevated compared to those of the 1-kb fusion gene. The increase in
luciferase levels when the 1-kb construct was assayed in the hspA-atrR background
compared to the wild-type was less than 2-fold. This supports the notion that the
region from 100 to 1,300 bp upstream of the ATG of abcG1 may contain the AtrR-
responsive region.
Sequence inspection of this same upstream region showed the presence of two
potential ATREs (see Table 1). We carried out DNase I protection analysis of this portion
of the abcG1 promoter using recombinant AtrR as described above for cyp51A (Fig. 8B).
This analysis demonstrated the presence of two ATREs in this region of the abcG1
promoter and provides a molecular understanding for the defective AtrR response of
the 1-kb reporter gene that lacks these two elements.
The expression level of AtrR is important during pathogenesis. A loss of atrR
was previously shown to strongly reduce virulence in a mouse model of aspergillosis
(13). Here, we have described two new hyperactive alleles of atrR and wanted to
determine what impact these would have on virulence in this murine model. We used
a lung inhalation model (25) to test the impact of loss of a key AtrR target gene, the ABC
transporter-encoding abcG1 locus, or overproduction of AtrR itself (hspA-atrR) on fungal
virulence. Mice were challenged with these strains along with an isogenic wild-type
control and survival followed over an 11-day time course (Fig. 9).
We found that elevating the expression of AtrR via insertion of the hspA promoter
led to a delay in mortality caused by this strain. A loss of atrR rendered the resulting
mutant strain avirulent, as reported before. In this model, loss of the abcG1 gene did
not have an observable effect on virulence, contrary to results in found in a Galleria
model of infection (16). These data argue that the precise level of AtrR is crucial for
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FIG 8 AtrR binding and function at abcG1. (A) Three different abcG1-ﬁreﬂy luciferase (fLUC) reporter genes were integrated into the following
three indicated isogenic genetic backgrounds: atrRΔ mutant, wt (atrR), and an AtrR-overproducing strain (hspA-atrR mutant) at the hisB locus.
Representative transformants were grown to mid-log phase, whole-cell protein extracts were prepared, and levels of ﬁreﬂy luciferase were
assayed using a standard method as described previously (14). The promoter sequence present is denoted as no-promoter (only fLUC cassette),
1 kb or 1.3 kb of abcG1 5= noncoding DNA (relative to the ATG). P values are indicated as described in the Fig. 2 legend. (B) DNase I protection
analysis using recombinant AtrR and a cloned segment of the abcG1 promoter (1066 to 895 bp from the transcription start site) as a DNA
probe. The protected regions are indicated on the sequence shown at the left in yellow boxes. The transcription start site is shown by the arrow,
and the ATG and the start of the coding sequence for abcG1 (blue box) are indicated.
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normal virulence. Normal pathogenesis thus requires a particular optimal dosage of
AtrR with either elevated or depressed levels causing virulence defects in the animal
model, a so-called “Goldilocks effect.”
DISCUSSION
Our identiﬁcation of the ATRE as a component of the 34-bp region in the cyp51A
promoter adds an important new element to an already crowded regulatory region. As
seen for SRE1 (9), the ATRE is duplicated in the TR34 repeat, consistent with this AtrR
being a key contributor to the elevated gene transcription found in the presence of this
promoter alteration. A second common cyp51A promoter variant, called TR46 (26),
would also contain two SREs and two ATREs, supporting the view that the duplication
of binding sites for both of these factors is required for the observed increment in gene
expression in both TR mutants. Further analysis of the TR34/46 duplications is required
to determine which parts of these duplicated promoters are hyperactive. At least in the
case of the TR34 promoter, although the CBC recognition site is duplicated, it does not
TABLE 1 A. fumigatus strains used in this study
Strain Parent Genotype Reference or source
AfS35 D141 akuAΔ::loxP FGSC
SPF87 AfS35 atrRΔ::ptrA This study
SPF89 AfS35 atrR-3 HA::hph 13
SPF108 AfS35 ptrA::hspA-atrR This study
SPF112 SPF89 ptrA::hspA-atrR-3 HA::hph This study
SPF84 AfS35 abcG1Δ::loxP 16
SPF110 SPF84 abcG1Δ ptrA::hspA-atrR This study
SPF134 AfS35 srbAΔ::hph This study
SPF137 SPF108 srbAΔ ptrA::hspA-atrR This study
SPF114 SPF87 atrRΔ hisBΔ::fLUC::hph This study
SPF116 SPF87 atrRΔ hisBΔ::1kb abcG1-fLUC::hph This study
SPF118 SPF87 atrRΔ hisBΔ::1.3kb abcG1-fLUC::hph This study
SPF119 AfS35 hisBΔ::fLUC::hph This study
SPF121 AfS35 hisBΔ::1kb abcG1-fLUC::hph This study
SPF123 AfS35 hisBΔ::1.3kb abcG1-fLUC::hph This study
SPF124 SPF108 hspA-atrR hisBΔ::fLUC::hph This study
SPF126 SPF108 hspA-atrR hisBΔ::1kb abcG1-fLUC::hph This study
SPF128 SPF108 hspA-atrR hisBΔ::1.3kb abcG1-fLUC::hph This study
hspA-atrR
abcG1
atrR
wt
FIG 9 Effect of atrR alleles and abcG1Δ mutation on virulence. Eight mice per strain of A. fumigatus were
immunosuppressed with cortisone acetate and then infected in an aerosol chamber and monitored for
survival. Note that PBS control data are not distinguishable from atrRΔ infection. P for this experiment,
0.0001, P for pairwise comparison of hspA-atrR and wt  0.03, by the log-rank rank sum test.
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appear to be a functional binding site (9). This suggests that only the downstream
CBC/HapX-repressive interaction is operational and possibly that the upstream dupli-
cated 34-bp region is free of this normal repression.
The steady-state accumulation of AtrR at the protein level is sensitive to the form of
this factor that is produced. The presence of the 3 HA epitope tag at the C terminus
of AtrR caused the protein to behave as a hypermorphic allele and to exhibit lowered
steady-state levels compared to the wild-type factor. Even when atrR-3 HA is driven
by the hspA promoter, the resulting steady-state level is almost the same as when
driven by the native atrR promoter. We cannot eliminate the possibility that replace-
ment of the wild-type atrR promoter with that of the much stronger hspA element fails
to increase the transcription of atrR-3 HA, although this is seen to occur in a
comparison of wild-type atrR and hspA-atrR. Hyperactive transcription factors have
been associated with more rapid degradation through ubiquitin-dependent means
(27), and we speculate that this is true for the AtrR-3 HA protein. These data are
consistent with the insertion of the 3 HA tag causing some alteration in the structure
of AtrR that blocks proper control by a presumptive negative regulatory signal. We
argue that since the expression level of AtrR is not increased at the protein or mRNA
level, the elevated transcription rate that the AtrR-3 HA supports is due to a change
in the activity of this protein. Similarly, elevated expression of the native factor appears
to exceed the capacity of this negative regulation to restrain the transcriptional
activation of AtrR. These suggestions are consistent with the hypothesis that the cause
of hyperactivity of these two different atrR alleles is not the same. Both of these
observations are consistent with the notion that AtrR is normally subject to negative
regulation.
The large number of genes containing ChIP-seq peaks corresponding to AtrR was an
unexpected observation. Earlier work identiﬁed approximately 120 genes as containing
SREs and being transcriptionally responsive to SrbA (18, 22). Our ChIP-seq analysis
detected nearly 900 genes with a signiﬁcant association with AtrR, but fewer than 20%
of these were induced in the presence of either hypermorphic allele of atrR used.
Approximately 200 (atrR-3 HA) or 600 (hspA-atrR) genes were respectively induced in
hypermorphic atrR backgrounds, but a minority of these induced genes contained
ATREs. This is most readily interpreted by the majority of the transcriptional induction
seen in these strains resulting from indirect effects. We hypothesize that AtrR occupies
a relatively upstream position in the network of transcription factors that impact gene
regulation in A. fumigatus, as supported by the GO term enrichment for these factors
in the ChIP-seq data (Table S1). When AtrR is activated, it can induce the expression and
function of a number of other transcriptional regulatory proteins and the circuits they
directly control. We suggest that the full spectrum of transcriptional responses to
changes in AtrR activity consist of a relatively smaller number of direct target genes (i.e.,
abcG1 and cyp51A) and a larger collection of genes that are activated via AtrR control
of genes encoding other transcription factors (i.e., srbA and srbB).
While our data strongly support the ability of a sequence element with the
CGG(N)12CCG as being sufﬁcient to function as an ATRE in vivo, this single consensus
is not sufﬁcient to explain the entire range of target genes bound by AtrR. As can be
seen in Table 2 and Fig. 3B, the precise consensus for in vivo ATREs is likely to be more
complex and will require further characterization. Our ﬁnding of the important tandem
ATREs located more than 1 kb upstream of the ATG in abcG1 illustrates the potentially
increased complexity for A. fumigatus promoter organization compared to similar
regions in more extensively characterized fungi, such as Saccharomyces cerevisiae
(reviewed in reference 28).
Finally, the hypovirulent phenotype caused by either loss of atrR or overproduction
of the wild-type factor illustrates the importance of the dosage of AtrR during patho-
genesis. The normal disease process required a properly metered level of this protein
and suggests that interventions targeting the activity of this transcriptional regulator
might be effective in interfering with the pathogenicity of this important fungus. The
essential role AtrR plays in azole resistance would also be impacted by interfering with
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normal function of this transcription factor. Recent experiments describing the suc-
cessful identiﬁcation of a drug preventing normal transcription factor activation (29)
suggest that this strategy might be effective to reduce AtrR-dependent transactivation
as well. Further understanding of the molecular details explaining AtrR control of gene
expression is essential to develop strategies to accomplish this goal.
MATERIALS AND METHODS
Strains and growth conditions. All strains used in this study were derived from the AfS35 (FGSC
#A1159) strain and are listed in Table 1. A. fumigatus strains were typically grown at 37°C in rich medium
(Sabouraud dextrose; 0.5% tryptone, 0.5% peptone, 2% dextrose [pH 5.6  0.2]). Selection of transfor-
mants was made in minimal medium (MM; 1% glucose, nitrate salts, trace elements, 2% agar [pH 6.5]);
trace elements, vitamins, and nitrate salts are as described in the appendix of reference 30, supple-
mented with 1% sorbitol and either 200 mg/liter hygromycin Gold (InvivoGen) or 0.1 mg/liter pyrithia-
mine. For solid medium, 1.5% agar was added. For both ChIP- and RNA-seq experiments, all cells were
cultured on rich Sabouraud dextrose medium as bioﬁlms prior to the isolation of either ﬁxed chromatin
or RNA, respectively.
Derivatives containing the hspA-atrR construct were made as follows: 4 DNA fragments consisting of
1,000 bp upstream of the atrR coding sequence, -rec/six-ptrA blaster cassette (from pSK485), hspA
promoter, and 1,000 bp corresponding to the atrR 5= coding sequence were joined by Gibson assembly
at the BamH1 site of pUC19 to form pSP99. This plasmid was then digested with SmaI and PmeI to release
the 8.5-kb integration construct from the plasmid backbone and transformed into AfS35, SPF89, and
SPF844 to generate strains SPF108, SPF112, and SPF110, respectively, under pyrithiamine selection.
The srbAΔ disruption strain was generated using a hygromycin split-marker strategy (31). The
split-marker cassettes were constructed by fusion PCR. The upstream split marker had a 1.2-kb region
corresponding to the DNA segment immediately upstream of the srbA gene, followed by a partial
hygromycin cassette. The downstream split marker had a 1.2-kb DNA fragment corresponding to the
region immediately downstream of the srbA gene preceded by the complementary partial hygromycin
cassette. The hygromycin partial cassettes contained a 600-bp overlap between the split markers. The
upstream and downstream split markers were cotransformed into the AfS35 and the SPF108 strain to
generate SPF134 and SPF137, respectively.
The abcG1 promoter-luciferase strains were generated as follows: an A. fumigatus hisB (Afu6g04700)
targeting construct was initially made in a pRS316 vector backbone containing 1.2 kb DNA upstream of
the hisB gene, the complete hygromycin cassette, ﬁreﬂy luciferase gene (from the pGL3 plasmid
[Promega Corp., Madison, WI]), and 1.2-kb DNA downstream of the hisB gene using Gibson assembly. This
plasmid was named pSP62 and was digested with PmeI and AscI to insert either the 1-kb or 1.3-kb abcG1
promoter fragment just upstream of the luciferase reporter gene to generate pSP101a and pSP101b. The
pSP62, pSP100a, and pSP100b plasmids were digested with NotI and KpnI to release the integration
construct from the vector and transformed in SPF87, AfS35, and SPF108 strain backgrounds to generate
the different transcriptional fusion reporter strains given in Table 1.
Drug diffusion/spot assay. Fresh spores of A. fumigatus were suspended in 1 phosphate-buffered
saline (PBS) supplemented with 0.01% Tween 20 (1 PBST). The spore suspension was counted using a
hemocytometer to determine the spore concentration. Spores were then appropriately diluted in 1
PBST. For the drug diffusion assay, 106 spores were mixed with 10 ml soft agar (0.7%) and poured over
15 ml regular agar containing (1.5%) minimal medium. A paper disk was placed on the center of the
plate, and 10 l of either 1 mg/liter voriconazole or 20 mg/liter ﬂuconazole was spotted onto the ﬁlter
paper. For the spot assay, 100 spores (in 4 l) were spotted on minimal medium with or without the
drug. The plates were incubated at 37°C and inspected for growth every 12 h.
Generation of an AtrR antibody. A region of 597 bp (corresponding to the 199 N-terminal amino
acids) from atrR were PCR ampliﬁed and cloned in frame as BamHI/SalI fragments downstream of the
6-His tag in pET28a (EMD Millipore, Inc.) to form pGT3 and transformed into the bacterial strain
Escherichia coli BL21(DE3). Two liters of transformed bacteria was grown to log phase and induced with
isopropyl--D-thiogalactopyranoside (IPTG) for 90 min. Cell lysates were prepared using a French press.
Protein puriﬁcation was accomplished using Talon metal afﬁnity resin (TaKaRa Bio USA, Inc.) as described
TABLE 2 ATREs from selected genesa
Upstream endpoint ATRE Downstream endpoint Locus
308 CGGATGTGTGCTGAGCCG 291 cyp51A
842 CGGGGTTAACGGCTTCCG 825 atrR
1132 CGGAGCTTACCAGATCCGA 1114 abcG1
1183 CGGATCAGTAGGATCCCG 1166
754 CGGAATCGCTTCTTCCCG 737 srbA
617 CGGTAGCCATGATGAtCG 600 erg25
770 CGGAGTTTCGTCCAAtCG 753 erg5
1081 CGGCCATTCGGATATCCG 1064 erg6
aNumbers refer to distance upstream of the respective ATG, while the bolded letters indicate the conserved
triplet.
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by the manufacturer. Protein fractions were analyzed by staining them with Coomassie blue and by
Western blotting using His-speciﬁc antibodies. The puriﬁed proteins were then lyophilized and sent to
Paciﬁc Immunology (Ramona, CA) for injection into rabbits to generate polyclonal antibodies against
AtrR. Antiserum generated from these rabbits was received and tested for immunoreactivity against A.
fumigatus cell lysates. The antiserum was then puriﬁed using an AminoLink Plus coupling resin (Thermo
Scientiﬁc, Inc.) according to the manufacturer’s instructions, and the afﬁnity-puriﬁed antiserum was used
to detect the AtrR protein from A. fumigatus cell lysates.
Western blotting. Western blotting was performed as described in reference 32. The rabbit AtrR
polyclonal antibody was used at a 1:100 dilution, while the anti-AbcG1 antibody was used at a 1:1,000
dilution.
Real-time PCR. Quantitative reverse transcription-PCR (qRT-PCR) was performed as described in
reference 32, with the exception that cell lysates were prepared from mycelial bioﬁlm cultures formed
upon inoculating 106 spores in a petri dish containing 20 ml of Sabouraud dextrose broth and grown for
24 h at 37°C under nonshaking conditions. The threshold cycle (CT) value of the act1 transcript was used
as a normalization control.
ChIP-seq. Chromatin immunoprecipitation (ChIP) was done as described in reference 13. Puriﬁed
ChIP-ed DNA was then subjected to library preparation as outlined in reference 33, with the following
modiﬁcations. The puriﬁed ChIP-ed DNA was concentrated to 10 l using a SpeedVac system and the
libraries set up using the Rubicon ThruPLEX DNA-seq kit with 10 l as the input volume. The paired reads
were mapped to the Af293 A. fumigatus genome using Bowtie 2 (34). The MACS2 algorithm was used to
call signiﬁcant read depth peaks upon comparing epitope-tagged samples to the untagged wild-type
control (35). ChIP-seq peaks were analyzed for proximity to annotated protein-coding genes using the
ChIPPeakAnno package (36). A fasta ﬁle was generated containing 250 bp on each side of signiﬁcant
peak summits and analyzed for conserved motifs using MEME-ChIP (37). A summary of all next-
generation sequencing (NGS) data (ChIP- and RNA-seq) is provided in Table S2.
RNA-seq. RNA was prepared as described in reference 32, with the exception that cell lysates for RNA
were prepared as described above for generating samples for qRT-PCR. RNA samples were quantiﬁed
using ﬂuorimetry, and RNA quality was assessed using the Agilent 2100 Bioanalyzer. Sequencing libraries
were generated using the TruSeq stranded mRNA sample preparation kit (Illumina, Inc., San Diego, CA)
and, following Illumina’s sample preparation guide, started with 500 ng of input total RNA. The molar
concentrations of the indexed libraries were measured using the 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA) with a high-sensitivity chip, and the libraries were combined equally into one pool. The
molar concentration of the pool was measured using the Kapa Illumina library quantiﬁcation kit (Kapa
Biosystems, Wilmington, MA), and the pool was sequenced on one lane of the Illumina HiSeq 4000
sequencer with 75-bp paired-end SBS chemistry (Illumina). Paired-end reads were mapped to the Af293
A. fumigatus genome using HISAT2 (38). Transcript assembly, quantiﬁcation of expression levels, and
analysis of differential expression were done using StringTie and Ballgown (39).
EMSA. Radiolabeled EMSA was performed using the protocol described in reference 40, with the
following modiﬁcations: a probe corresponding to the cyp51A promoter was PCR ampliﬁed using the
GAAAAAACTCATGAGTGAATAATCG (sense [S]) and CATGCTGTATTTTATATTCACCTACC (antisense [AS])
primer pair. This region contained the 34 bp that is duplicated in the cyp51A TR34 allele and is associated
with clinically relevant azole-resistant strains. The atrR probe was ampliﬁed using the CTAGATCCTGGA
TTCATGGCTC (S) and CGACTAACCACAATCGACTGG (AS) primer pair, the abcG1 probe ampliﬁed using the
TGTACGGAGTATATCCATAGCTG (S) and GTGACAAAAACTCCGCTAGCA (AS) primer pair, and the srbA
probe ampliﬁed using the AGGGCAGGTAACGTTACAGCC (S) and GAATTGCTGCCTGTGCCTGAG (AS)
primer pair. All of these probes were designed such that they corresponded to the AtrR ChIP-seq peak
region for their respective promoters. Aliquots of each probe were end-labeled with [-32P]-ATP and T4
polynucleotide kinase. For competitive binding, 40-fold molar excess of the nonradiolabeled probe was
added to the binding reaction.
Biotin-labeled EMSA was performed as follows: biotin-labeled oligonucleotides used in the reaction
corresponded to the 34-bp sequence in the cyp51A promoter that is duplicated (TR34) in many
drug-resistant clinical isolates and were ordered from IDT (Coralville, IA). The sense strands of the
competitor nonlabeled oligonucleotides are listed in Fig. 7B. The complementary strands of the labeled
and unlabeled oligonucleotides were annealed by heating at 95°C and gradual cooling to room
temperature prior to use as probes. The binding reaction for recombinant AtrR-DNA binding domain
(AtrR-DBD; 0.1 g/reaction) was done in the presence of 25 mM Tris-HCl (pH 7.5), 80 mM NaCl, 35 mM
KCl, 5 mM MgCl2, 10% glycerol, and 1 g poly(dI-dC) in a 20-l reaction volume. Twenty picomoles
biotinylated probe was used per reaction. When nonlabeled probes were used, they were in 12-fold
molar excess to the labeled probe. Incubation was done at room temperature for 30 min. DNA and
protein-DNA complexes were resolved by electrophoresis at 100 V on a 5% native acrylamide gel at room
temperature using a buffer containing 45 mM Tris (pH 8.0), 45 mM boric acid, and 1 mM EDTA (TBE). DNA
was electrotransferred from the gel to a nylon membrane (Hybond-N  Amersham) in 0.5 TBE buffer
at 100 V for 30 min. The membrane was then blocked in 1% SDS in Odyssey blocking buffer (PBS) for 30
min, replaced with fresh blocking buffer plus 1% SDS, and incubated in 1:10,000 streptavidin-680 nm
IRDye (Li-Cor) for 30 min at room temperature. The membrane was then washed three times in 1 PBST
for 5 min each, followed by scanning using a LiCor Odyssey infrared imaging system, application
software version 3.0, and quantiﬁed using the Image Studio Lite 4.0 software (LiCor).
DNase I footprinting. DNase I footprinting assay was carried out as described in reference 40, with
the following modiﬁcations: for generation of the cyp51A probe, a PCR product corresponding to 453 to
191 bp upstream of the translation start site containing the 34 bp duplicated in TR34 was cloned into
Transcriptional Regulation by AtrR ®
March/April 2019 Volume 10 Issue 2 e02563-18 mbio.asm.org 17
 o
n
 January 20, 2020 at TSUKUBA DAIG
AKU
http://m
bio.asm
.org/
D
ow
nloaded from
 
pCR2.1-TOPO. This plasmid was digested with SalI, treated with calf intestinal alkaline phosphatase,
phosphorylated with T4 polynucleotide kinase and [-32P]-ATP, and ﬁnally cleaved with HindIII. For
generation of the abcG1 probe, a PCR product of the abcG1 promoter containing 1,210 to 1,039 bp
upstream of the abcG1 translation start site, including the ChIP-seq peak region, was cloned into
pCR2.1-TOPO. This plasmid was digested with SalI, treated with calf intestinal alkaline phosphatase,
phosphorylated with T4 polynucleotide kinase and [-32P]-ATP, and ﬁnally cleaved with MluI.
Luciferase assay. Fireﬂy luciferase assays were done using the ﬁreﬂy luciferase assay kit procured
from Biotium, Inc., as described in reference 14.
Mouse model of invasive aspergillosis. To investigate the virulence of various strains, we used a
nonneutropenic mouse model of invasive aspergillosis (41). Brieﬂy, 6-week-old and 20- to 22-g male
BALB/c mice (Taconic Laboratories) were immunosuppressed with 7.5 mg cortisone acetate (Sigma-
Aldrich) administered subcutaneously every other day from day 4 before infection to day 4 after infection, for
a total of 5 doses. To prevent bacterial infection, enroﬂoxacin (Baytril; Western Medical Supply) was added to
the drinking water at a ﬁnal concentration of 0.005% the day before beginning the cortisone acetate
treatment. Next, 11 to 12 mice per group were infected in an acrylic chamber exposing them for 1 h to an
aerosol generated from 12ml of PBS containing 109 conidia/ml. Immediately after infection, 3 mice from each
group were sacriﬁced, and lungs were harvested, homogenized, and quantitatively cultured to verify the
delivery of conidia to the lungs. The remaining mice were monitored twice daily for survival assessment. As
a negative control, 8 mice were immunosuppressed but not infected.
Data availability. All NGS data are available as a linked GEO SuperSeries accession number
GSE123446.
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